{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:32:33Z","timestamp":1762079553190,"version":"build-2065373602"},"reference-count":43,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institutes of Health","award":["R01-HL143830","R56-HL146133"],"award-info":[{"award-number":["R01-HL143830","R56-HL146133"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>In this study, we aimed to investigate whether short-term and low-dose treatment with hydroxychloroquine (HCQ), an antimalarial drug, can modulate heart function in a preclinical model of dilated cardiomyopathy (DCM) expressing the D94A mutation in cardiac myosin regulatory light chain (RLC) compared with healthy non-transgenic (NTg) littermates. Increased interest in HCQ came with the COVID-19 pandemic, but the risk of cardiotoxic side effects of HCQ raised concerns, especially in patients with an underlying heart condition, e.g., cardiomyopathy. Effects of HCQ treatment vs. placebo (H2O), administered in Tg-D94A vs. NTg mice over one month, were studied by echocardiography and muscle contractile mechanics. Global longitudinal strain analysis showed the HCQ-mediated improvement in heart performance in DCM mice. At the molecular level, HCQ promoted the switch from myosin\u2019s super-relaxed (SRX) to disordered relaxed (DRX) state in DCM-D94A hearts. This result indicated more myosin cross-bridges exiting a hypocontractile SRX-OFF state and assuming the DRX-ON state, thus potentially enhancing myosin motor function in DCM mice. This bottom-up investigation of the pharmacological use of HCQ at the level of myosin molecules, muscle fibers, and whole hearts provides novel insights into mechanisms by which HCQ therapy mitigates some abnormal phenotypes in DCM-D94A mice and causes no harm in healthy NTg hearts.<\/jats:p>","DOI":"10.3390\/ijms232415589","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T01:51:26Z","timestamp":1670550686000},"page":"15589","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hydroxychloroquine Mitigates Dilated Cardiomyopathy Phenotype in Transgenic D94A Mice"],"prefix":"10.3390","volume":"23","author":[{"given":"Rosemeire M.","family":"Kanashiro-Takeuchi","sequence":"first","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"},{"name":"Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-2666","authenticated-orcid":false,"given":"Katarzyna","family":"Kazmierczak","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingsheng","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauro M.","family":"Takeuchi","sequence":"additional","affiliation":[{"name":"Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel H.","family":"Sitbon","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8441-0722","authenticated-orcid":false,"given":"Danuta","family":"Szczesna-Cordary","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, FL 33136, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"key":"ref_1","first-page":"153333","article-title":"Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus","volume":"79","author":"Wang","year":"2020","journal-title":"Phytomedicine Int. J. Phytother. PhytoPharm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/15563650500514558","article-title":"Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia","volume":"44","author":"Chen","year":"2006","journal-title":"Clin. Toxicol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/2048872612471215","article-title":"Hydroxychloroquine cardiotoxicity presenting as a rapidly evolving biventricular cardiomyopathy: Key diagnostic features and literature review","volume":"2","author":"Joyce","year":"2013","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100747","DOI":"10.1016\/j.nmni.2020.100747","article-title":"Hydroxychloroquine is protective to the heart, not harmful: A systematic review","volume":"37","author":"Prodromos","year":"2020","journal-title":"New Microbes New Infect."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/hrt.69.5.451","article-title":"Restrictive cardiomyopathy caused by chloroquine","volume":"69","year":"1993","journal-title":"Br. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E2338","DOI":"10.1073\/pnas.1716925115","article-title":"Sarcomeric perturbations of myosin motors lead to dilated cardiomyopathy in genetically modified MYL2 mice","volume":"115","author":"Yuan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e2110328119","DOI":"10.1073\/pnas.2110328119","article-title":"Molecular basis of force-pCa relation in MYL2 cardiomyopathy mice: Role of the super-relaxed state of myosin","volume":"119","author":"Yuan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/febs.13286","article-title":"Novel familial dilated cardiomyopathy mutation in MYL2 affects the structure and function of myosin regulatory light chain","volume":"282","author":"Huang","year":"2015","journal-title":"FEBS J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.hfc.2017.12.004","article-title":"Genetic Pathogenesis of Hypertrophic and Dilated Cardiomyopathy","volume":"14","author":"Garfinkel","year":"2018","journal-title":"Heart Fail. Clin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/eurheartj\/ehv727","article-title":"Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: A position statement of the ESC working group on myocardial and pericardial diseases","volume":"37","author":"Pinto","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated Cardiomyopathy: Genetic Determinants and Mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ. Res."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Lopez-Ruiz, N., and Uribe, C.E. (2014). Chloroquine cardiomyopathy: Beyond ocular adverse effects. BMJ Case Rep., 2014.","DOI":"10.1136\/bcr-2014-205751"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"E4138","DOI":"10.1073\/pnas.1505819112","article-title":"Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice","volume":"112","author":"Yuan","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Dulce, R.A., Kanashiro-Takeuchi, R.M., Takeuchi, L.M., Salerno, A.G., Wanschel, A., Kulandavelu, S., Balkan, W., Zuttion, M., Cai, R., and Schally, A.V. (2022). Synthetic growth hormone-releasing hormone agonist ameliorates the myocardial pathophysiology characteristic of HFpEF. Cardiovasc. Res., cvac098.","DOI":"10.1093\/cvr\/cvac098"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"795","DOI":"10.21037\/atm.2020.04.10","article-title":"Understanding ventriculo-arterial coupling","volume":"8","author":"Santos","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/cvr\/cvx060","article-title":"Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice","volume":"113","author":"Yuan","year":"2017","journal-title":"Cardiovasc. Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.2042-7158.1986.tb04635.x","article-title":"Effects of chloroquine and didesethylchloroquine on rabbit myocardium and mitochondria","volume":"38","author":"Essien","year":"1986","journal-title":"J. Pharm. Pharm."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e12413","DOI":"10.14814\/phy2.12413","article-title":"High-dose chloroquine is metabolically cardiotoxic by inducing lysosomes and mitochondria dysfunction in a rat model of pressure overload hypertrophy","volume":"3","author":"Chaanine","year":"2015","journal-title":"Physiol. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Goulter, A.B., Goddard, M.J., Allen, J.C., and Clark, K.L. (2004). ACE2 gene expression is up-regulated in the human failing heart. BMC Med., 2.","DOI":"10.1186\/1741-7015-2-19"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s003800200043","article-title":"Comparison of treatment effects of bevantolol and metoprolol on cardiac function and natriuretic peptides in patients with dilated cardiomyopathy","volume":"17","author":"Hara","year":"2002","journal-title":"Heart Vessel."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.96.2.509","article-title":"Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: Prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction","volume":"96","author":"Tsutamoto","year":"1997","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"e148637","DOI":"10.1172\/jci.insight.148637","article-title":"Serum circulating proteins from pediatric patients with dilated cardiomyopathy cause pathologic remodeling and cardiomyocyte stiffness","volume":"6","author":"Jeffrey","year":"2021","journal-title":"JCI Insight"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ijcard.2007.12.109","article-title":"Can NT-proBNP predict risk of cardiovascular mortality within 10 years? Results from an epidemiological study of elderly patients with symptoms of heart failure","volume":"133","author":"Alehagen","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/S0002-8703(97)80014-2","article-title":"Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure","volume":"134","author":"Tsutamoto","year":"1997","journal-title":"Am. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gil-Cayuela, C., Rosello, L.E., Ortega, A., Tarazon, E., Trivino, J.C., Martinez-Dolz, L., Gonzalez-Juanatey, J.R., Lago, F., Portoles, M., and Rivera, M. (2016). New Altered Non-Fibrillar Collagens in Human Dilated Cardiomyopathy: Role in the Remodeling Process. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0168130"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.mayocp.2020.03.024","article-title":"Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)","volume":"95","author":"Giudicessi","year":"2020","journal-title":"Mayo Clin. Proc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1016\/j.bpj.2011.02.061","article-title":"A new state of cardiac Myosin with very slow ATP turnover: A potential cardioprotective mechanism in the heart","volume":"100","author":"Hooijman","year":"2011","journal-title":"Biophys. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e24634","DOI":"10.7554\/eLife.24634","article-title":"Effects of myosin variants on interacting-heads motif explain distinct hypertrophic and dilated cardiomyopathy phenotypes","volume":"6","author":"Alamo","year":"2017","journal-title":"Elife"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1111\/febs.15243","article-title":"Ablation of the N terminus of cardiac essential light chain promotes the super-relaxed state of myosin and counteracts hypercontractility in hypertrophic cardiomyopathy mutant mice","volume":"287","author":"Sitbon","year":"2020","journal-title":"FEBS J."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/febs.14702","article-title":"Phosphomimetic-mediated in vitro rescue of hypertrophic cardiomyopathy linked to R58Q mutation in myosin regulatory light chain","volume":"286","author":"Yadav","year":"2019","journal-title":"FEBS J."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Krishnasamy, R., Isbel, N.M., Hawley, C.M., Pascoe, E.M., Burrage, M., Leano, R., Haluska, B.A., Marwick, T.H., and Stanton, T. (2015). Left Ventricular Global Longitudinal Strain (GLS) Is a Superior Predictor of All-Cause and Cardiovascular Mortality When Compared to Ejection Fraction in Advanced Chronic Kidney Disease. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0127044"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2045894019841987","DOI":"10.1177\/2045894019841987","article-title":"Echocardiographic assessment of right ventricular function in experimental pulmonary hypertension","volume":"9","author":"Zhu","year":"2019","journal-title":"Pulm. Circ."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Bourke, L., McCormick, J., Taylor, V., Pericleous, C., Blanchet, B., Costedoat-Chalumeau, N., Stuckey, D., Lythgoe, M.F., Stephanou, A., and Ioannou, Y. (2015). Hydroxychloroquine Protects against Cardiac Ischaemia\/Reperfusion Injury In Vivo via Enhancement of ERK1\/2 Phosphorylation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0143771"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"3803","DOI":"10.4049\/jimmunol.1400571","article-title":"Identification of Activators of ERK5 Transcriptional Activity by High-Throughput Screening and the Role of Endothelial ERK5 in Vasoprotective Effects Induced by Statins and Antimalarial Agents","volume":"193","author":"Le","year":"2014","journal-title":"J. Immunol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.hrthm.2015.05.027","article-title":"Hydroxychloroquine reduces heart rate by modulating the hyperpolarization-activated current If: Novel electrophysiological insights and therapeutic potential","volume":"12","author":"Capel","year":"2015","journal-title":"Heart Rhythm."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jmb.2006.06.018","article-title":"Prolonged Ca2+ and force transients in myosin RLC transgenic mouse fibers expressing malignant and benign FHC mutations","volume":"361","author":"Wang","year":"2006","journal-title":"J. Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41419-018-0378-3","article-title":"Hydroxychloroquine attenuates renal ischemia\/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation","volume":"9","author":"Tang","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"H575","DOI":"10.1152\/ajpheart.00107.2013","article-title":"Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy","volume":"305","author":"Kazmierczak","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jmb.2009.02.006","article-title":"The Role of the N-Terminus of the Myosin Essential Light Chain in Cardiac Muscle Contraction","volume":"387","author":"Kazmierczak","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.yjmcc.2014.06.011","article-title":"Hypertrophic Cardiomyopathy Associated Lys104Glu Mutation in the Myosin Regulatory Light Chain Causes Diastolic Disturbance in Mice","volume":"74","author":"Huang","year":"2014","journal-title":"J. Mol. Cell Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fphys.2014.00353","article-title":"Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations","volume":"5","author":"Kazmierczak","year":"2014","journal-title":"Front. Physiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1042\/BJ20111145","article-title":"Myosin Regulatory Light Chain Mutation Found In Hypertrophic Cardiomyopathy Patients Increases Isometric Force Production in Transgenic Mice","volume":"442","author":"Kazmierczak","year":"2012","journal-title":"Biochem. J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/15589\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:36:55Z","timestamp":1760146615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/24\/15589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":43,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijms232415589"],"URL":"https:\/\/doi.org\/10.3390\/ijms232415589","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2022,12,9]]}}}